Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-10-14A Multisite Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of ALVAC-HIV vCP1452 Alone and Combined With MN rgp120
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase I Trial to Evaluate the Safety and Immunogenicity of the HIV-1 pGA2/JS2 Plasmid DNA Vaccine Given Intramuscularly (IM) in HIV-1 Uninfected Adults
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of High-Dose Live Recombinant Canarypox ALVAC-HIV Vaccine (vCP1452) in Healthy, HIV-1 Uninfected Adult Participants
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase 1 Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of SAAVI DNA-C2 Vaccine Boosted by SAAVI MVA-C Vaccine, in HIV Uninfected Healthy Vaccinia Naive Adult Participants in South Africa and the United States
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase 1b Clinical Trial to Evaluate Mucosal Immune Responses to a DNA Plasmid Vaccine Prime Followed by an HIV-1 Adenoviral Vector Boost in Healthy Adenovirus Type 5 Seronegative HIV-1-uninfected Adults
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase I Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade, Multivalent Recombinant Adenoviral Vector HIV Vaccine, VRC-HIVADV014-00-VP, in Healthy, HIV-1 Uninfected Adult Participants Who Have Low Titers of Pre-Existing Ad5 Neutralizing Antibodies
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Clade B Gag DNA/PLG and Env DNA/PLG Microparticles Vaccine and a Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant Vaccine in Healthy, HIV-1 Uninfected Adult Participants
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX™-B (Gag, Pol, Env) Vaccine, With or Without IL-12 DNA Plasmid, Delivered Via Electroporation in Healthy, HIV-1-Uninfected Adult Participants
-
CLINICAL_TRIALS study record update · 2021-10-14A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA, in Healthy, HIV-Uninfected Adult Participants
-
CLINICAL_TRIALS study record update · 2021-10-08Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa (MONART Trial)
-
CLINICAL_TRIALS study record update · 2021-10-06Efficacy and Safety of Albuvirtide for Injection Combined With LPV/r for Treatment of HIV-1-Infected Patients Failed First-line Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2021-09-22A Two-Part Randomized Study to Evaluate the Relative Bioavailability of Temsavir Following Single Dose Administration of Fostemsavir 600 mg Tablets Compared to Two Fostemsavir 200 mg Tablet Formulations and to Evaluate the Effect of Food on Bioavailability of Selected Fostemsavir 200 mg Tablet Formulation in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2021-09-20A Stigma Reduction Intervention at Time of Entry Into Antenatal Care to Improve PMTCT Services in Tanzania (Maisha)
-
CLINICAL_TRIALS study record update · 2021-09-17Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
-
CLINICAL_TRIALS study record update · 2021-09-05Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs
-
CLINICAL_TRIALS study record update · 2021-08-30Is Dual Therapy as Effective as Triple Therapy Regarding CD4+/CD8+ Ratio Recovery and Improvement of Immune Activation and Inflammation in HIV-infected Patients With Consistent Plasma Viral Load Suppression (Tridual)
-
CLINICAL_TRIALS study record update · 2021-08-27Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV
-
CLINICAL_TRIALS study record update · 2021-08-23Open-Label, Dose-Escalating, Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous (SC) VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
-
CLINICAL_TRIALS study record update · 2021-08-18Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
-
CLINICAL_TRIALS study record update · 2021-08-17Symptom Management of HIV-related Diarrhea by Using Normal Foods: A Randomized Controlled Clinical Trial.
-
CLINICAL_TRIALS study record update · 2021-08-16FDG/PET Imaging for the Assessment of Brown Adipose Tissue in HIV Lipodystrophy
-
CLINICAL_TRIALS study record update · 2021-08-10Seroprevalence of SARS-CoV-2 Antibodies Among Adult Patients Living With HIV
-
CLINICAL_TRIALS study record update · 2021-08-05Menstrual Cups and Cash Transfer to Reduce Sexual and Reproductive Harm and School Dropout in Adolescent Schoolgirls in Western Kenya: a Cluster Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-07-28Developing and Testing the Effect of a Patient-Centered HIV Prevention Decision Aid on PrEP Uptake for Women With Substance Use in Treatment Settings
-
CLINICAL_TRIALS study record update · 2021-07-28Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks